GSK-LSD1

• Target :

  Histone Demethylase|||Apoptosis

• Related Pathways :

  Apoptosis|||Chromatin/Epigenetic

• Purity :

  0.9959

• Bioactivity :

  GSK-LSD1 is a selective LSD1 inhibitor with potential anticancer activity that attenuates the expression of CTGF/CCN2, MMP13, LOXL4, and waveform proteins in cancer cells.GSK-LSD1 regulates the cell cycle, induces apoptosis, and can be used to study breast cancer.

• Smiles :

  N([C@H]1[C@@H](C1)C2=CC=CC=C2)C3CCNCC3

• Molecular Formula :

  C14H20N2

• Molecular Weight :

  216.32

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1431368-48-7